All Stories

  1. Screening of Living Kidney Donors for Genetic Diseases: CON
  2. Initial experience from a renal genetics clinic demonstrates a distinct role in patient management
  3. Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases
  4. Billing for Living Kidney Donor Care: Balancing Cost Recovery, Regulatory Compliance, and Minimized Donor Burden
  5. Diagnosis of monogenic chronic kidney diseases
  6. Unusual presentation of Q fever in a kidney‐pancreas transplant recipient
  7. Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome
  8. VEGF-A selectively inhibits FLT1 ectodomain shedding independent of receptor activation and receptor endocytosis
  9. EGF regulation of proximal tubule cell proliferation and VEGF‐A secretion
  10. Has the Department of Veterans Affairs Found a Way to Avoid Racial Disparities in the Evaluation Process for Kidney Transplantation?
  11. Aldosterone regulates a 5ʹ variant sgk1 transcript via a shared hormone response element in the sgk1 5ʹ regulatory region
  12. An Unexpected Surge in Plasma BKPyV Viral Load Heralds the Development of BKPyV-Associated Metastatic Bladder Cancer in a Lung Transplant Recipient With BKPyV Nephropathy
  13. Screening of Living Kidney Donors for Genetic Diseases Using a Comprehensive Genetic Testing Strategy
  14. Familial C3 glomerulonephritis caused by a novel CFHR5-CFHR2 fusion gene
  15. Ectodomain cleavage of FLT1 regulates receptor activation and function and is not required for its downstream intracellular cleavage
  16. High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies
  17. Light Chain Deposition Disease After Kidney Transplantation With Long Graft Survival: Case Report
  18. BK polyoma virus infection and renal disease in non-renal solid organ transplantation
  19. Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy
  20. Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome
  21. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature
  22. Soluble C5b-9 as a Biomarker for Complement Activation in Atypical Hemolytic Uremic Syndrome
  23. Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1
  24. The Challenge in Diagnosing De Novo Minimal Change Disease After Transplantation
  25. Conversion to a sirolimus‐based regimen is associated with lower incidence of BK viremia in low‐risk kidney transplant recipients
  26. N-Terminal Cleavage and Release of the Ectodomain of Flt1 Is Mediated via ADAM10 and ADAM 17 and Regulated by VEGFR2 and the Flt1 Intracellular Domain
  27. Late-Onset BK Viral Nephropathy in a Kidney Transplant Recipient
  28. Comprehensive Genetic Analysis of Complement and Coagulation Genes in Atypical Hemolytic Uremic Syndrome
  29. Protein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGF/VEGF antagonist
  30. Faculty Opinions recommendation of Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension.
  31. Quiz Page April 2013
  32. A regulated NH2-terminal Sgk1 variant with enhanced function is expressed in the collecting duct
  33. Case Report: Eculizumab Rescue of Severe Accelerated Antibody-Mediated Rejection After ABO-Incompatible Kidney Transplant
  34. Tailored Eculizumab Therapy in the Management of Complement Factor H–Mediated Atypical Hemolytic Uremic Syndrome in an Adult Kidney Transplant Recipient: A Case Report
  35. Secretion of Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1/sFlt1) Requires Arf1, Arf6, and Rab11 GTPases
  36. Very Early Recurrence of Anti-Phospholipase A2 Receptor-Positive Membranous Nephropathy After Transplantation
  37. Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression
  38. Pre-emptive Eculizumab and Plasmapheresis for Renal Transplant in Atypical Hemolytic Uremic Syndrome
  39. Dextran Removal by Plasmapheresis in a Kidney-Pancreas Transplant Recipient With Dextran 40–Induced Osmotic Nephrosis
  40. Nedd4–2 interacts with occludin to inhibit tight junction formation and enhance paracellular conductance in collecting duct epithelia
  41. Alternate processing of Flt1 transcripts is directed by conserved cis -elements within an intronic region of FLT1 that reciprocally regulates splicing and polyadenylation
  42. Unrecognized Acute Phosphate Nephropathy in a Kidney Donor with Consequent Poor Allograft Outcome
  43. A Recently Evolved Novel Trophoblast-Enriched Secreted Form of fms-Like Tyrosine Kinase-1 Variant Is Up-Regulated in Hypoxia and Preeclampsia
  44. Recurrent Atypical Hemolytic Uremic Syndrome Associated With Factor I Mutation in a Living Related Renal Transplant Recipient
  45. An evolutionarily conserved N-terminal Sgk1 variant with enhanced stability and improved function
  46. A genetic syndrome of chronic renal failure with multiple renal cysts and early onset diabetes
  47. Nedd4-2 isoforms ubiquitinate individual epithelial sodium channel subunits and reduce surface expression and function of the epithelial sodium channel
  48. Serum/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival
  49. Intronic polyadenylation signal sequences and alternate splicing generate human soluble Fltl variants and regulate the abundance of soluble Flt1 in the placenta
  50. Diffuse Glomerular Crescents and Peritubular Immune Deposits in a Transplant Kidney
  51. Medroxyprogesterone acetate binds the glucocorticoid receptor to stimulate α-ENaC and sgk1 expression in renal collecting duct epithelia
  52. Nedd4–2 isoforms differentially associate with ENaC and regulate its activity
  53. Early Postnephrectomy Donor Renal Function: Laparoscopic versus Open Procedure
  54. Dual Therapeutic Utility of Proteasome Modulating Agents for Pharmaco-gene Therapy of the Cystic Fibrosis Airway
  55. cAMP-stimulated Na+transport in H441 distal lung epithelial cells: role of PKA, phosphatidylinositol 3-kinase, and sgk1
  56. AVP-induced VIT32 gene expression in collecting duct cells occurs via trans-activation of a CRE in the 5′-flanking region of the VIT32 gene
  57. New insights into epithelial sodium channel function in the kidney: site of action, regulation by ubiquitin ligases, serum- and glucocorticoid-inducible kinase and proteolysis
  58. Transcriptional repression of the CTP:phosphocholine cytidylyltransferase gene by sphingosine
  59. Systemic Pseudohypoaldosteronism from Deletion of the Promoter Region of the HumanβEpithelial Na+Channel Subunit
  60. The  -Subunit of the Epithelial Sodium Channel Is an Aldosterone-Induced Transcript in Mammalian Collecting Ducts, and This Transcriptional Response Is Mediated via Distinct cis-Elements in the 5'-Flanking Region of the Gene
  61. Glucocorticoid Induction of Epithelial Sodium Channel Expression in Lung and Renal Epithelia Occurs via trans-Activation of a Hormone Response Element in the 5′-Flanking Region of the Human Epithelial Sodium Channel α Subunit Gene
  62. The structure of the rat amiloride-sensitive epithelial sodium channel gamma subunit gene and functional analysis of its promoter
  63. Genomic Organization and the 5′ Flanking Region of the γ Subunit of the Human Amiloride-sensitive Epithelial Sodium Channel